FDA Drug Application (021168) for DEPAKOTE ER by ABBVIE

Back to FDA Applications sponsored by ABBVIE

Application Number021168
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
DosageEQ 500MG VALPROIC ACID
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDEPAKOTE ER
Active IngredientDIVALPROEX SODIUM

Active IngredientCount
List of drugs with Active Ingredient DIVALPROEX SODIUM4


Back to FDA Applications sponsored by ABBVIE